1,082
Views
35
CrossRef citations to date
0
Altmetric
Original Research

Prostate cancer stem cells are targets of both innate and adaptive immunity and elicit tumor-specific immune responses

, , , , , , , , , & show all
Article: e24520 | Received 07 Dec 2012, Accepted 02 Apr 2013, Published online: 16 Apr 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Hajar Rajayi, Parsova Tavasolian, Alaleh Rezalotfi & Marzieh Ebrahimi. (2019) Cancer Stem Cells Targeting; the Lessons from the Interaction of the Immune System, the Cancer Stem Cells and the Tumor Niche. International Reviews of Immunology 38:6, pages 267-283.
Read now
ShuChen Lin, YingChun Xu, ZhiHua Gan, Kun Han, HaiYan Hu, Yang Yao, MingZhu Huang & DaLiu Min. (2016) Monitoring cancer stem cells: insights into clinical oncology. OncoTargets and Therapy 9, pages 731-740.
Read now
Loretta Gammaitoni, Valeria Leuci, Giulia Mesiano, Lidia Giraudo, Maja Todorovic, Fabrizio Carnevale-Schianca, Massimo Aglietta & Dario Sangiolo. (2014) Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospective. Expert Opinion on Biological Therapy 14:9, pages 1259-1270.
Read now

Articles from other publishers (32)

Farideh Hashemi, Mahdieh Razmi, Fatemeh Tajik, Margot Zöller, Masoumeh Dehghan Manshadi, Forough Mahdavinezhad, Amir Tiyuri, Roya Ghods & Zahra Madjd. (2023) Efficacy of Whole Cancer Stem Cell-Based Vaccines: A Systematic Review of Preclinical and Clinical Studies. Stem Cells 41:3, pages 207-232.
Crossref
Carlo Sorrentino, Luigi D’Antonio, Stefania Livia Ciummo, Cristiano Fieni, Lorena Landuzzi, Francesca Ruzzi, Simone Vespa, Paola Lanuti, Lavinia Vittoria Lotti, Pier Luigi Lollini & Emma Di Carlo. (2022) CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality. Journal of Hematology & Oncology 15:1.
Crossref
Om Saswat Sahoo, Karthikeyan Pethusamy, Tryambak P. Srivastava, Joyeeta Talukdar, Mohammed S. Alqahtani, Mohamed Abbas, Ruby Dhar & Subhradip Karmakar. (2022) The metabolic addiction of cancer stem cells. Frontiers in Oncology 12.
Crossref
Charles T. Lutz, Lydia Livas, Steven R. Presnell, Morgan Sexton & Peng Wang. (2021) Gender Differences in Urothelial Bladder Cancer: Effects of Natural Killer Lymphocyte Immunity. Journal of Clinical Medicine 10:21, pages 5163.
Crossref
Eda Acikgoz, Leyla Sati, Burak Cem Soner & Gulperi Oktem. 2021. Successes and Challenges of NK Immunotherapy. Successes and Challenges of NK Immunotherapy 439 457 .
Sara Caputo, Matteo Grioni, Chiara S. Brambillasca, Antonella Monno, Arianna Brevi, Massimo Freschi, Ignazio S. Piras, Angela R. Elia, Valentina Pieri, Tania Baccega, Angelo Lombardo, Rossella Galli, Alberto Briganti, Claudio Doglioni, Elena Jachetti & Matteo Bellone. (2020) Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis. Frontiers in Immunology 11.
Crossref
Saurabh Pratap Singh, Richa Singh, Om Prakash Gupta, Shalini Gupta & Madan Lal Brahma Bhatt. (2020) Immunotherapy: Newer Therapeutic Armamentarium against Cancer Stem Cells. Journal of Oncology 2020, pages 1-15.
Crossref
Emma Di Carlo. (2020) Decoding the Role of Interleukin-30 in the Crosstalk between Cancer and Myeloid Cells. Cells 9:3, pages 615.
Crossref
Carlo Sorrentino, Zhinan Yin, Stefania Ciummo, Paola Lanuti, Li-Fan Lu, Marco Marchisio, Matteo Bellone & Emma Di Carlo. (2019) Targeting Interleukin(IL)-30/IL-27p28 signaling in cancer stem-like cells and host environment synergistically inhibits prostate cancer growth and improves survival. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Changhao Fu, Ning Zhou, Yuanyuan Zhao, Jinyue Duan, Hao Xu & Yi Wang. (2019) Dendritic cells loaded with CD44+ CT‑26 colon cell lysate evoke potent antitumor immune responses. Oncology Letters.
Crossref
Roberto Ruiu, Lidia Tarone, Valeria Rolih, Giuseppina Barutello, Elisabetta Bolli, Federica Riccardo, Federica Cavallo & Laura Conti. 2019. Cancer Immunotherapy. Cancer Immunotherapy 119 188 .
Saad Rasool, Sergio Rutella, Soldano Ferrone & Cristina Maccalli. 2019. Cancer Stem Cell Resistance to Targeted Therapy. Cancer Stem Cell Resistance to Targeted Therapy 223 249 .
Matteo Bellone & Sara Caputo. 2019. Cancer Stem Cell Resistance to Targeted Therapy. Cancer Stem Cell Resistance to Targeted Therapy 173 221 .
Dingxiao Zhang, Dean G. Tang & Kiera Rycaj. (2018) Cancer stem cells: Regulation programs, immunological properties and immunotherapy. Seminars in Cancer Biology 52, pages 94-106.
Crossref
Sergej Skvortsov, Ira-Ida Skvortsova, Dean G. Tang & Anna Dubrovska. (2018) Concise Review: Prostate Cancer Stem Cells: Current Understanding. Stem Cells 36:10, pages 1457-1474.
Crossref
Carlo Sorrentino, Stefania L. Ciummo, Giuseppe Cipollone, Sara Caputo, Matteo Bellone & Emma Di Carlo. (2018) Interleukin-30/IL27p28 Shapes Prostate Cancer Stem-like Cell Behavior and Is Critical for Tumor Onset and Metastasization. Cancer Research 78:10, pages 2654-2668.
Crossref
Mirjana Pavlovi?Ksenija Radoti?Mirjana Pavlovi?Ksenija Radoti?. 2017. Animal and Plant Stem Cells. Animal and Plant Stem Cells 7 16 .
Mirjana Pavlović & Ksenija RadotićMirjana Pavlović & Ksenija Radotić. 2017. Animal and Plant Stem Cells. Animal and Plant Stem Cells 113 123 .
Mirjana Pavlović & Ksenija RadotićMirjana Pavlović & Ksenija Radotić. 2017. Animal and Plant Stem Cells. Animal and Plant Stem Cells 93 97 .
Ahmed Z. Gad, Shahenda El-Naggar & Nabil Ahmed. (2016) Realism and pragmatism in developing an effective chimeric antigen receptor T-cell product for solid cancers. Cytotherapy 18:11, pages 1382-1392.
Crossref
Yangyang Hu, Lin Lu, Yang Xia, Xin Chen, Alfred E. Chang, Robert E. Hollingsworth, Elaine Hurt, John Owen, Jeffrey S. Moyer, Mark E.P. Prince, Fu Dai, Yangyi Bao, Yi Wang, Joel Whitfield, Jian-Chuan Xia, Shiang Huang, Max S. Wicha & Qiao Li. (2016) Therapeutic Efficacy of Cancer Stem Cell Vaccines in the Adjuvant Setting. Cancer Research 76:16, pages 4661-4672.
Crossref
Zhongwu Su, Guo Li, Chao Liu, Shuling Ren, Yongquan Tian, Yong Liu & Yuanzheng Qiu. (2016) Ionizing radiation promotes advanced malignant traits in nasopharyngeal carcinoma via activation of epithelial-mesenchymal transition and the cancer stem cell phenotype. Oncology Reports.
Crossref
Sinh Nguyen Truong & Phuc Van Pham. (2015) Stem cell technology and engineering for cancer treatment. Biomedical Research and Therapy 2:6.
Crossref
Elena Jachetti, Sara Caputo, Stefania Mazzoleni, Chiara Svetlana Brambillasca, Sara Martina Parigi, Matteo Grioni, Ignazio Stefano Piras, Umberto Restuccia, Arianna Calcinotto, Massimo Freschi, Angela Bachi, Rossella Galli & Matteo Bellone. (2015) Tenascin-C Protects Cancer Stem–like Cells from Immune Surveillance by Arresting T-cell Activation. Cancer Research 75:10, pages 2095-2108.
Crossref
Si-Ming Wei, Jin-Xuan Fei, Feng Tao, Hang-Li Pan, Qing Shen, Li Wang, Yu-Jia Wu, Li Zhou, Sheng-Xin Zhu, Wei-Bin Liao, Hua Ji & Zhao-Liang Xin. (2015) Anti-CD27 Antibody Potentiates Antitumor Effect of Dendritic Cell–Based Vaccine in Prostate Cancer–Bearing Mice. International Surgery 100:1, pages 155-163.
Crossref
Mirjana Pavlovic & Bela BalintMirjana Pavlovic & Bela Balint. 2015. Bioengineering and Cancer Stem Cell Concept. Bioengineering and Cancer Stem Cell Concept 57 70 .
Mirjana Pavlovic & Bela BalintMirjana Pavlovic & Bela Balint. 2015. Bioengineering and Cancer Stem Cell Concept. Bioengineering and Cancer Stem Cell Concept 43 56 .
Veronica Catalano, Cecilia Eleuteri, Gaia Campoccia, Gianluca Giacobini, Mariangela Zane, Giorgio Stassi, Giorgio Parmiani & Cristina Maccalli. 2015. Resistance of Cancer Cells to CTL-Mediated Immunotherapy. Resistance of Cancer Cells to CTL-Mediated Immunotherapy 3 29 .
Luis Fernando Tume Farfán. (2014) La inmunoterapia en la búsqueda de antígenos contra las células madre del cáncer. Inmunología 33:3, pages 96-109.
Crossref
Monalisa Ghosh, Sam J. Brancato, Piyush K. Agarwal & Andrea B. Apolo. (2014) Targeted therapies in urothelial carcinoma. Current Opinion in Oncology 26:3, pages 305-320.
Crossref
Vetvicka Vaclav, Richter Josef, Kral Vlastimil, Pohorska Jitka, Stiborova Ivana, Rajnohova Dobiasova Lucie, Vincikova Andrea & Jilek Dalibor. (2014) Effects of ?-glucans on benign hyperplasia of prostate. Pathology Discovery 2:1, pages 8.
Crossref
Andrew S. Goldstein & Owen N. Witte. (2013) Does the microenvironment influence the cell types of origin for prostate cancer?. Genes & Development 27:14, pages 1539-1544.
Crossref